Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spontaneous breathing trial with pressure support on positive end-expiratory pressure and extensive use of non-invasive ventilation versus T-piece in difficult-to-wean patients from mechanical ventilation: a randomized controlled trial.
Mezidi M, Yonis H, Chauvelot L, Deniel G, Dhelft F, Gaillet M, Noirot I, Folliet L, Chabert P, David G, Danjou W, Baboi L, Bettinger C, Bernon P, Girard M, Provoost J, Bazzani A, Bitker L, Richard JC. Mezidi M, et al. Among authors: provoost j. Ann Intensive Care. 2024 Apr 17;14(1):59. doi: 10.1186/s13613-024-01290-6. Ann Intensive Care. 2024. PMID: 38630372 Free PMC article.
Adverse Events and Infectious Complications in the Critically Ill Treated by Plasma Exchange: A Five-Year Multicenter Cohort Study.
François M, Daubin D, Menouche D, Gaillet A, Provoost J, Trusson R, Arrestier R, Hequet O, Richard JC, Moranne O, Larcher R, Klouche K. François M, et al. Among authors: provoost j. Crit Care Explor. 2023 Oct 27;5(11):e0988. doi: 10.1097/CCE.0000000000000988. eCollection 2023 Nov. Crit Care Explor. 2023. PMID: 38304709 Free PMC article.
Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study.
Chabert P, Provoost J, Cohen S, Dupieux-Chabert C, Bitker L, Ferry T, Goutelle S, Richard JC. Chabert P, et al. Among authors: provoost j. Ann Intensive Care. 2022 Sep 30;12(1):90. doi: 10.1186/s13613-022-01059-9. Ann Intensive Care. 2022. PMID: 36175707 Free PMC article.
Prevalence and risk factors of hemodynamic instability associated with preload-dependence during continuous renal replacement therapy in a prospective observational cohort of critically ill patients.
Chazot G, Bitker L, Mezidi M, Chebib N, Chabert P, Chauvelot L, Folliet L, David G, Provoost J, Yonis H, Richard JC. Chazot G, et al. Among authors: provoost j. Ann Intensive Care. 2021 Jun 14;11(1):95. doi: 10.1186/s13613-021-00883-9. Ann Intensive Care. 2021. PMID: 34125314 Free PMC article.
Quantitative-analysis of computed tomography in COVID-19 and non COVID-19 ARDS patients: A case-control study.
Chauvelot L, Bitker L, Dhelft F, Mezidi M, Orkisz M, Davila Serrano E, Penarrubia L, Yonis H, Chabert P, Folliet L, David G, Provoost J, Lecam P, Boussel L, Richard JC. Chauvelot L, et al. Among authors: provoost j. J Crit Care. 2020 Dec;60:169-176. doi: 10.1016/j.jcrc.2020.08.006. Epub 2020 Aug 13. J Crit Care. 2020. PMID: 32854088 Free PMC article.
Type I IFN immunoprofiling in COVID-19 patients.
Trouillet-Assant S, Viel S, Gaymard A, Pons S, Richard JC, Perret M, Villard M, Brengel-Pesce K, Lina B, Mezidi M, Bitker L, Belot A; COVID HCL Study group. Trouillet-Assant S, et al. J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29. J Allergy Clin Immunol. 2020. PMID: 32360285 Free PMC article. No abstract available.
Toward effective use of REACH data for science and policy.
Fantke P, Aurisano N, Provoost J, Karamertzanis PG, Hauschild M. Fantke P, et al. Among authors: provoost j. Environ Int. 2020 Feb;135:105336. doi: 10.1016/j.envint.2019.105336. Epub 2019 Dec 26. Environ Int. 2020. PMID: 31884133 Free article. No abstract available.
The impact on classifications for carcinogenicity, mutagenicity, reproductive and specific target organ toxicity after repeated exposure in the first ten years of the REACH regulation.
Karamertzanis PG, Atlason P, Nathanail AV, Provoost J, Karhu E, Rasenberg M. Karamertzanis PG, et al. Among authors: provoost j. Regul Toxicol Pharmacol. 2019 Aug;106:303-315. doi: 10.1016/j.yrtph.2019.05.003. Epub 2019 May 11. Regul Toxicol Pharmacol. 2019. PMID: 31085250
12 results